HYL — Hyloris Pharmaceuticals SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Hyloris Pharmaceuticals SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	—	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.205	64.4	50.5	43.9	30.7
Net Total Accounts Receivable
Net Total Receivables	0.333	0.253	2.32	5.13	4.1
Total Other Current Assets
Total Current Assets	3.74	66.6	54	50.8	35.3
Net Property, Plant And Equipment	0.098	0.176	0.295	1.06	2.15
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	5.98	69.2	63.4	61.9	47.6
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16.1	2.13	15	5.77	6.94
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	16.2	10.1	15.4	6.82	8.79
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-10.2	59.1	48.1	55	38.8
Total Liabilities & Shareholders' Equity	5.98	69.2	63.4	61.9	47.6
Total Common Shares Outstanding